Table 3.
Comparison of clinical characteristics between patients with and without recurrence after the first eradication
| Patients with recurrence (N = 50) | Patients without recurrence (N = 179)a | P | |
| Male gender, n (%) | 39 (78.0) | 125 (69.8) | 0.26 |
| Age (yr) | 54.2 ± 5.6 | 50.1 ± 10.8 | <0.001 |
| CPC-A, n (%) | 8 (16.0) | 107 (59.8) | <0.001 |
| NSBB responders, n (%) | 10 (20.0) | 84 (46.9) | 0.001 |
| PVT at entry, n (%) | 15 (30.0) | 27 (15.1) | 0.02 |
| Procedure by senior endoscopists, n (%) | 39 (78.0) | 123 (68.7) | 0.20 |
| Red color signs on varices at entry, n (%) | 23 (46.0) | 44 (24.6) | 0.003 |
| EVL for eradication, n (%) | 35 (70.0) | 79 (44.1) | 0.001 |
| Complete eradication, n (%) | 22 (44.0) | 136 (76.0) | <0.001 |
| Rebleeding, n (%) | 12 (24.0) | 14 (7.8) | 0.001 |
| Rebleeding before eradication, n (%) | 2 (4.0) | 6 (3.4) | 0.69 |
| Rebleeding after eradication, n (%) | 10 (20.0) | 8 (4.5) | <0.001 |
CPC, Child-Pugh classification; EVL, endoscopic variceal ligation; HBV, hepatitis B virus; NSBB, nonselective β blocker; PVT, portal vein thrombosis.
a
Eleven patients died, were transferred to alternative therapies, or lost to follow-up before they achieved eradication of EVs.